EUDA said the wide availability and use of an increasingly diverse range of substances, often of high potency or purity, is posing a serious risk to public health.
The EU drug agency sees vapes and e-cigarettes as a possible gateway to new designer drugs. At the same time, it registers more cannabis from overseas, new synthetic substances and an increasing use of ketamine.